Diagnostic and Prognostic Value of Cytogenetics in Acute Myeloid LeukemiaGRIMWADE, David; MROZEK, Krzysztof.Hematology/oncology clinics of North America. 2011, Vol 25, Num 6, issn 0889-8588, vii, 1135-1161 [28 p.]Article

Prognostic value of cytogenetic findings in adults with acute myeloid leukemiaMROZEK, Krzysztof; HEINONEN, Kristiina; BLOOMFIELD, Clara D et al.International journal of hematology. 2000, Vol 72, Num 3, pp 261-271, issn 0925-5710Article

Cytogenetics in acute leukemiaMROZEK, Krzysztof; HEEREMA, Nyla A; BLOOMFIELD, Clara D et al.Blood reviews. 2004, Vol 18, Num 2, pp 115-136, issn 0268-960X, 22 p.Article

Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics : Myeloid diseaseMARCUCCI, Guido; MROZEK, Krzysztof; BLOOMFIELD, Clara D et al.Current opinion in hematology. 2005, Vol 12, Num 1, pp 68-75, issn 1065-6251, 8 p.Article

Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia : recent advancesMROZEK, Krzysztof; DÖHNER, Hartmut; BLOOMFIELD, Clara D et al.Current opinion in hematology. 2007, Vol 14, Num 2, pp 106-114, issn 1065-6251, 9 p.Article

Clinical importance of cytogenetics in acute myeloid leukaemiaMROZEK, Krzysztof; HEINONEN, Kristiina; BLOOMFIELD, Clara D et al.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, pp 19-47, issn 1521-6926Article

Molecular signatures in acute myeloid leukemiaMROZEK, Krzysztof; RADMACHER, Michael D; BLOOMFIELD, Clara D et al.Current opinion in hematology. 2009, Vol 16, Num 2, pp 64-69, issn 1065-6251, 6 p.Article

Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations : a concise reviewBALDUS, Claudia D; MROZEK, Krzysztof; MARCUCCI, Guido et al.British journal of haematology. 2007, Vol 137, Num 5, pp 387-400, issn 0007-1048, 14 p.Article

Cancer and leukemia Group B leukemia correlative science committee : Major accomplishments and future directionsBLOOMFIELD, Clara D; MROZEK, Krzysztof; CALIGIURI, Michael A et al.Clinical cancer research. 2006, Vol 12, Num 11, issn 1078-0432, 3564s-3571s, 2Article

Cytogenetic, Molecular Genetic, and Clinical Characteristics of Acute Myeloid Leukemia With a Complex KaryotypeMROZEK, Krzysztof.Seminars in oncology. 2008, Vol 35, Num 4, pp 365-377, issn 0093-7754, 13 p.Article

Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosisSEEWALDT, Victoria L; MROZEK, Krzysztof; DIETZE, Eric C et al.Cancer research (Baltimore). 2001, Vol 61, Num 2, pp 616-624, issn 0008-5472Article

The prognostic and functional role of microRNAs in acute myeloid leukemiaMARCUCCI, Guido; MROZEK, Krzysztof; RADMACHER, Michael D et al.Blood. 2011, Vol 117, Num 4, pp 1121-1129, issn 0006-4971, 9 p.Article

Cytogenetics and Molecular Genetics of Acute Lymphoblastic LeukemiaMROZEK, Krzysztof; HARPER, David P; APLAN, Peter D et al.Hematology/oncology clinics of North America. 2009, Vol 23, Num 5, issn 0889-8588, v-vi, 991-1010 [22 p.]Article

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics : are we ready for a prognostically prioritized molecular classification?MROZEK, Krzysztof; MARCUCCI, Guido; PASCHKA, Peter et al.Blood. 2007, Vol 109, Num 2, pp 431-448, issn 0006-4971, 18 p.Article

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML, within the ELN Favorable genetic categoryMETZELER, Klaus H; BECKER, Heiko; POWELL, Bayard L et al.Blood. 2011, Vol 118, Num 26, pp 6920-6929, issn 0006-4971, 10 p.Article

Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studyBECKER, Heiko; MARCUCCI, Guido; WU, Yue-Zhong et al.Blood. 2010, Vol 116, Num 5, pp 788-792, issn 0006-4971, 5 p.Article

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21) : A cancer and leukemia group B studyPASCHKA, Peter; MARCUCCI, Guido; KOLITZ, Jonathan E et al.Journal of clinical oncology. 2006, Vol 24, Num 24, pp 3904-3911, issn 0732-183X, 8 p.Article

Additional cytogenetic abnormalities in adults with philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group BWETZLER, Meir; DODGE, Richard K; MROZEK, Krzysztof et al.British journal of haematology. 2004, Vol 124, Num 3, pp 275-288, issn 0007-1048, 14 p.Article

Adult de novo acute myeloid Leukemia with t(6;11)(q27;q23): Results from cancer and Leukemia Group B study 8461 and review of the literatureBLUM, William; MROZEK, Krzysztof; RUPPERT, Amy S et al.Cancer. 2004, Vol 101, Num 6, pp 1420-1427, issn 0008-543X, 8 p.Article

The partial nontandem duplication of the MLL (ALL1) gene is a novel rearrangement that generates three distinct fusion transcripts in B-cell acute lymphoblastic leukemiaWHITMAN, Susan P; STROUT, Matthew P; CALIGIURI, Michael A et al.Cancer research (Baltimore). 2001, Vol 61, Num 1, pp 59-63, issn 0008-5472Article

Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid LeukemiaMARCUCCI, Guido; METZELER, Klaus H; WU, Yue-Zhong et al.Journal of clinical oncology. 2012, Vol 30, Num 7, pp 742-750, issn 0732-183X, 9 p.Article

RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression SignaturesMENDLER, Jason H; MAHARRY, Kati; NICOLET, Deedra et al.Journal of clinical oncology. 2012, Vol 30, Num 25, pp 3109-3118, issn 0732-183X, 10 p.Article

IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B StudyMARCUCCI, Guido; MAHARRY, Kati; METZELER, Klaus H et al.Journal of clinical oncology. 2010, Vol 28, Num 14, pp 2348-2355, issn 0732-183X, 8 p.Article

Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B StudySCHWIND, Sebastian; MAHARRY, Kati; PASCHKA, Peter et al.Journal of clinical oncology. 2010, Vol 28, Num 36, pp 5257-5264, issn 0732-183X, 8 p.Article

FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplicationsWHITMAN, Susan P; RUPPERT, Amy S; KOLITZ, Jonathan E et al.Blood. 2008, Vol 111, Num 3, pp 1552-1559, issn 0006-4971, 8 p.Article